Orion Group Holdings, Inc.
NYSE:ORNEngineering & Construction
+$0.48 today
- Market cap
- $300.07M
- Beta
- 1.38
- P/E (TTM)
- 73.6
- EPS (TTM)
- $0.21
Volume 0.92M
Average 0.34M
ORN EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Orion Group Holdings, Inc.NYSE: ORN
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA dips below year-ago levels
Q1 FY2026 EBITDA of $5.15M fell 12.3% year over year, behind the +9.9% change in trailing-twelve-month EBITDA. Sequentially, it fell 54.1% from the prior quarter. Over 3 fiscal years it compounded at +56.4% a year.
Context
- EBITDA amounted to 5.0% of revenue in FY2025, up 1.0 pp from a year earlier.
- EBITDA increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 5 analysts of $52.66M (+24.5%) for the fiscal year ending Dec 2026, a slowdown from the +34.7% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $5.15M-54.1% QoQ
- Last fiscal yearDec 2025
- $42.29M+34.7% YoY
- LTMMar 2026
- $38.14M+9.9% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -12.3% | +71.7% | +84.0 pp |
| 1 year | +34.7% | +24.5% | -10.2 pp |
| 3-year CAGR | +56.4% | +21.6% | -34.8 pp |
| 5-year CAGR | +17.0% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 42.29M USD
- Year-over-year change
- +34.7%
- 4-year CAGR
- +73.2%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 42.29M | +34.7% |
| FY2024 | 2024-12-31 | 31.39M | +100.1% |
| FY2023 | 2023-12-31 | 15.68M | +41.8% |
| FY2022 | 2022-12-31 | 11.06M | +135.5% |
| FY2021 | 2021-12-31 | 4.7M | — |
EBITDA vs competitors
How ORN compares with its peers on the latest reported figures
- Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +9.9% is the 6th highest of 10, against a peer median of +10.6%.
- EBITDA amounts to 4.3% of revenue for ORN, versus a peer median of 10.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Apr 2026 | $99.66M USD | -3.3% | -7.8% | 24.3% | |
| LTM Apr 2026 | $81.29M USD | -72.0% | -35.9% | 5.3% | |
| LTM Feb 2026 | $75.72M USD | +10.6% | -0.8% | 19.3% | |
| LTM Mar 2026 | $38.14M USD | +9.9% | +56.4% | 4.3% | |
| LTM Mar 2026 | $16.9M USD | +51.8% | +11.6% | 23.1% | |
| LTM Feb 2026 | $13.05M USD | +24.7% | — | 10.8% | |
| LTM Apr 2026 | -$1.98M USD | -103.6% | — | 0.4% | |
| LTM Mar 2026 | -$4.62M USD | +60.4% | — | 0.5% | |
SRTAStrata Critical Medical, Inc. | LTM Mar 2026 | -$6.82M USD | +67.1% | — | 2.7% |
| LTM Mar 2026 | -$14.37M USD | -144.5% | — | 77.4% | |
| LTM Mar 2026 | -£325.37M GBP | — | — | — | |
| Peer median (excluding ORN) | — | +10.6% | -4.3% | 10.8% | |
Competitors are the stored peer set for ORN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 601.36M | 748.32M | 711.78M | 796.39M | 852.26M |
| Cost of Revenue | 560.39M | 697.58M | 650.12M | 705.23M | 746.65M |
| Gross Profit | 40.97M | 50.74M | 61.66M | 91.16M | 105.61M |
| Gross Margin | 6.8% | 6.8% | 8.7% | 11.4% | 12.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 60.18M | 62.5M | 69.43M | 82.54M | 93.47M |
| Operating Expenses | 50.28M | 58.77M | 68.29M | 79.64M | 93.47M |
| Depreciation & Amortization | 25.43M | 24.06M | 23.88M | 22.77M | 30.52M |
| EBITDA | 4.7M | 11.06M | 15.68M | 31.39M | 42.29M |
| EBITDA Margin | 0.8% | 1.5% | 2.2% | 3.9% | 5.0% |
| Operating Income | (9.32M) | (8.03M) | (6.63M) | 11.52M | 12.14M |
| Operating Margin | -1.5% | -1.1% | -0.9% | 1.4% | 1.4% |
| Interest Income | 136K | 104K | 103K | 207K | 0 |
| Interest Expense | 5.08M | 4.46M | 11.66M | 13.38M | 8.56M |
| Other Income / Expenses | (4.74M) | (4.15M) | (10.92M) | (12.82M) | (9.24M) |
| Income Before Tax | (14.06M) | (12.18M) | (17.55M) | (1.3M) | 2.91M |
| Pre-Tax Margin | -2.3% | -1.6% | -2.5% | -0.2% | 0.3% |
| Income Tax Expense | 502K | 429K | 330K | 348K | 419K |
| Net Income | (14.56M) | (12.61M) | (17.88M) | (1.64M) | 2.49M |
| Net Margin | -2.4% | -1.7% | -2.5% | -0.2% | 0.3% |
| EPS (Basic) | (0.47) | (0.40) | (0.55) | (0.05) | 0.06 |
| EPS (Diluted) | (0.47) | (0.40) | (0.55) | (0.05) | 0.06 |
| Weighted Avg Shares | 30.76M | 31.4M | 32.35M | 34.78M | 39.63M |
| Weighted Avg Shares (Diluted) | 30.76M | 31.4M | 32.35M | 34.78M | 39.64M |
Orion Group Holdings, Inc.
NYSE:ORN
Intrinsic Alpha fair value
Locked
Current Price
$7.38
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.